The Beauty Health Company SEC Filings

Form 4 Overview – The Beauty Health Company (SKIN)

Director Desiree Gruber filed a Form 4 reporting the award of 73,051 Class A common-stock RSUs on 16 June 2025. The award was coded “A” (acquired) and represents equity compensation rather than an open-market purchase. After this grant, Gruber’s total beneficial ownership rises to 192,565 shares, all held directly.

Vesting Terms

• The RSUs vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the 2026 annual meeting of shareholders.
• Continuous board service is required through the vesting date.

Key Takeaways for Investors

• The filing signals continued board-level alignment with shareholders, although the grant is part of the regular director compensation program rather than a discretionary purchase.
• No derivative securities transactions were reported, and no shares were disposed of.
• The transaction does not alter the company’s cash position or share count today, but it will have a modest dilutive effect upon vesting.

Twist Bioscience Corporation (TWST) – Form 144 filing: Director-level insider Dennis H. Cho has filed notice to sell 230 common shares through Fidelity Brokerage on or about 20 June 2025. At the reference market price, the proposed sale is valued at $8,223.58. The shares were recently acquired via restricted-stock vesting on 18 June 2025, and represent a negligible 0.0004 % of the company’s approximately 59.9 million shares outstanding.

The filing also discloses Cho’s activity over the preceding three months: seven open-market transactions totaling 6,925 shares for gross proceeds of roughly $231 k. While Rule 144 filings are routine for insiders liquidating vested stock, a pattern of recurring sales can signal personal portfolio rebalancing or modest profit-taking. No new information is provided regarding Twist’s operations, financial performance or outlook; the filer expressly states that he possesses no undisclosed adverse information about the company.

Form 4 filing for The Beauty Health Company (SKIN) discloses that director Michelle C. Kerrick was granted 73,051 restricted stock units (RSUs) on 06/16/2025 (Transaction Code A).

• The RSUs vest on the earlier of the one-year anniversary of the grant or the date of the company’s 2026 annual shareholders’ meeting, subject to her continued board service.
• After the grant, Kerrick’s total beneficial ownership increases to 189,813 Class A shares, held directly.
• No derivative securities were involved and no shares were sold.

The filing represents routine director equity compensation and does not indicate any open-market buying or selling activity.

Beauty Health Company (ticker: SKIN) filed a Form 4 disclosing an insider equity grant. Director Brian Christopher Miller received 73,051 Class A common-stock RSUs on 16 June 2025. The award is classified as an acquisition (Code A) and is part of routine director compensation.

The RSUs will vest on the earlier of the one-year anniversary of the grant or the 2026 annual shareholder meeting, subject to Miller’s continued board service. Following the grant, Miller’s beneficial ownership increased to 243,035 shares, held directly. No derivative securities or sales were reported, and no 10b5-1 trading plan was indicated.

Beauty Health Company (SKIN) – Form 4 insider filing

Director Doug K. Schillinger reported the grant of 73,051 restricted stock units (RSUs) on 16 Jun 2025. The award is coded "A" (acquisition) and is part of the company’s director compensation program rather than an open-market purchase. Vesting occurs on the earlier of (i) the one-year anniversary of the grant or (ii) the 2026 annual shareholders’ meeting, subject to the director’s continued board service.

Following this grant, Schillinger’s total beneficial ownership increased to 216,035 Class A common shares, all held directly. No derivative securities were reported.

The filing signals continued equity-based alignment between the board and shareholders but does not, by itself, alter Beauty Health’s financial outlook or capital structure.

On 20 June 2025, Permian Basin Royalty Trust (NYSE: PBT) filed a Form 8-K under Item 2.02 to report that it has released a press announcement (Exhibit 99.1) regarding its regular monthly cash distribution. Unitholders on record as of 30 June 2025 will qualify for the payment. The filing explicitly states that the information is being furnished, not filed, thereby avoiding Section 18 liability.

No distribution amount, payment date, production data or other operating metrics were included. Aside from listing the exhibit, the document contains no additional financial statements or material events.